Period (from – till): 12 November 2018 - 23 November 2018
Dr. J.A. Korporaal (coordinator) Laboratory for Experimental Cardiology, UMC Utrecht
Tel: 088-7556513 Email: J.A.Korporaalemail@example.com
Dr. R.T. Urbanus DLA, LKCH, UMC Utrecht
Dr. J.A. Korporaal DHL, Experimental Cardiology, UMC Utrecht
Haemostasis is an essential process in the prevention of blood loss as it facilitates undisturbed blood flow in the vasculature, resulting in the arrest of bleeding in response to injury of a blood vessel. Haemostasis consists of multiple components, including platelets, endothelial cells, and plasma proteins that together facilitate the coagulation cascade. Over the last 50 years, enormous progress has been made in understanding the role of platelets in haemostasis. Platelets circulate in blood in a resting state, but they are able to react immediately upon a vessel wall injury by adhering to the exposed collagen, followed by platelet-platelet interaction to form a plug that effectively seals the injured vessel wall to prevent excessive blood loss. Endothelial cells covering the vessel wall release inhibitors that prevent platelet aggregation, express proteins that inhibit the coagulation system, and synthesize components that stimulate the degradation of a fibrin clot. Similar to platelets, the coagulation system plays a crucial role in the maintenance of undisturbed blood flow. A hypo-active coagulation system will lead to a bleeding phenotype, while a hyper-active coagulation system increases the risk of thrombosis. Taken together, a well-balanced haemostatic system is thus essential for normal life. Inherited or acquired deficiencies may lead to an increased risk of bleeding or on the other hand to an increased risk of arterial and venous thrombosis.
The course will elaborate on the mechanisms responsible for the prevention of bleeding after injury (haemostasis) and the role of these mechanisms in the etiology of arterial and venous thrombosis. The biology of coagulation and the interaction between the vascular wall and circulating blood (cells) will be explained. In addition to basal biochemical sessions, the course will contain special sessions on therapeutic strategies, such as oral anticoagulants and thrombosis, state-of-the-art developments and valorization of laboratory tests, epidemiology of thrombosis, and biomarkers for thrombosis prediction. The students will train their knowledge of thrombosis and haemostasis in several work groups and students will get the opportunity to write a research proposal.
Will be provided at the course.
You can register via the study guide
. The maximum number of participants is 30.
BoD students: This course is one of the specific cardiovascular BoD-courses. Additional to the mandatory Kick off course, BoD students should accomplish 12 EC with specific (cardiovascular) BoD courses.
Optional for students from other programmes:
Yes. Admission of other students depends on their previous training.
Bachelor BMW, Biology or other Life Sciences. Basic knowledge of thrombosis and haemostasis.